IKT - Inhibikase Therapeutics Inc. (IKT) CEO Dr. Milton Werner on Q4 2021 Results - Earnings Call Transcript

Inhibikase Therapeutics, Inc. (IKT) Q4 2021 Results Conference Call April 1, 2022 08:00 AM ET Company Participants Alexander Lobo - Stern Investor Relations Dr. Milton Werner - Chief Executive Officer Joseph Frattaroli - Chief Financial Officer Presentation Operator Greetings, welcome to Inhibikase Therapeutics’ Fourth Quarter Full Year 2021 Financial Results. At this time, all participants are in listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. At this time I'll now turn the conference over to Alexander Lobo with Stern Investor Relations. Alexander, you may now begin. Alexander Lobo Good morning and welcome to Inhibikase Therapeutics Full Year 2021 Financial Results Conference Call and Audio Webcast. With me today are Dr. Milton Werner, Chief Executive Officer and Joseph Frattaroli, Chief Financial Officer. Yesterday afternoon Inhibikase Therapeutics issued a press release announcing financial results for the full year ended December

For further details see:

Inhibikase Therapeutics, Inc. (IKT) CEO Dr. Milton Werner on Q4 2021 Results - Earnings Call Transcript